GF Fund Management
NRIX icon

GF Fund Management’s Nurix Therapeutics NRIX Stock Holding History

GF Fund Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56.3K Buy
2,374
+194
+9% +$4.84K ﹤0.01% 378
2026
Q2 		$52.9K Sell
2,180
-86
-4% -$1.46K ﹤0.01% 383
2026
Q1 		$35.1K Buy
2,266
+274
+14% +$4.54K ﹤0.01% 441
2025
Q4 		$37.8K Buy
1,992
+347
+21% +$4.98K ﹤0.01% 432
2025
Q3 		$15.2K Sell
1,645
-169
-9% -$1.76K ﹤0.01% 522
2025
Q2 		$20.7K Hold
1,814
– – ﹤0.01% 498
2025
Q1 		$21.6K Buy
1,814
+327
+22% +$5.47K ﹤0.01% 496
2024
Q4 		$28K Buy
+1,487
New +$34.1K ﹤0.01% 440

Other funds holding NRIX

WestHill Financial Advisors
WestHill Financial Advisors San Rafael, California $597M AUM 13.09% 1-Year Est. Return
RAM Investment Partners
RAM Investment Partners Bellevue, Washington $631M AUM 11.73% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

GF Fund Management's NRIX Position: Q3 2026 in Review

GF Fund Management increased its Nurix Therapeutics (NRIX) stake by 8.9% in Q3 2026, buying an estimated $4.84K and bringing the position to 2,374 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

GF Fund Management first reported a position in NRIX in Q4 2024 and has held it in 8 quarters since. 20 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • GF Fund Management held 2,374 shares of Nurix Therapeutics worth $56.3K as of Q3 2026.
  • GF Fund Management bought 194 Nurix Therapeutics shares in Q3 2026, an estimated $4.84K.
  • Nurix Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #378 holding.
  • GF Fund Management first reported a position in Nurix Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 20 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.